Atlas Trials

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

Clinical trial NCT00327743 · COMPLETED

Trial details

NCT number
NCT00327743
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast CancerCancer
Start date
2006-08-01
Primary completion
2009-03-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.